Skip to main content

Table 4 The subgroup analysis results of pooing INB between the GLP1 agonists and DPP4 inhibitors

From: Meta-analysis of economic evaluation studies: data harmonisation and methodological issues

Subgroup analysis

No. of comparisons

Pooled INB (US$)

95% CI

p-value

I2 (%)

Threshold

  < Median ($49,325)

5

3,554.00

-1,825.34 to 8933.34

0.829

0.0

  ≥ Median ($49,325)

5

5,226.56

-3530.74 to 13,983.86

0.393

2.4

Time Horizon

 Life time

7

2,663.36

-2463.30 to 7790.01

0.852

0.0

 Non-lifetime

3

9,386.72

-846.73 to 19,620.17

0.424

0.0

Source of effectiveness

 Multiple study

4

1,538.51

-8,049.60 to 11,126.62

0.742

0.0

 Single study

6

4,745.01

-473.58 to 9,963.59

0.534

0.0